The graph below is results presented by the Director of the CDC to a Presidential briefing on April 17th, 2020. Prof. Dolores Cahill is a worldwide renowned expert in high-throughput proteomics technology development and automation, high content protein arrays, and their biomedical applications, including in biomarker discovery and diagnostics. Her knowledge and experiences span the globe. Below is a link to here explaining the information in the graph below. Lister to the narrative while viewing the graph. This is the best, most important, and concise overview of the science related to COVID-19 event you will ever hear.


Dolores Cahill, Professor, University College Dublin

Dolores Cahill ImageProf. Cahill received her degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology from Dublin City University in 1994. She was group leader of the Protein Technology Group in the Max-Planck-Institute of Molecular Genetics, Berlin, Germany (1996-2003) She co-founded a biotechnology company, Protagen AG ( in Dortmund to commercialise this technology. Since 2005, she is Professor of Translational Science at the UCD School of Medicine and Medical Sciences.

Her research, publication and patent record is in high content protein/antibody arrays and their biomedical applications. Application include the characterization of antibodies specificity (including therapeutic antibodies), biomarker discovery validation, diagnostics, assay development, protein-interaction studies, proteomics, large scale/systems biology research.

She is a member of a number of Editorial and Science Advisory and Review Boards. For the past 10 years she has been involved in policy development in the areas of science, technology and innovation, including in the EU Health, Innovation and Infrastructure. Since 2003, she is a Member of the Irish Government’s Advisory Science Council (ASC) (, appointed by the Minister for Industry, Trade and Employment. For the past ten years, she is on a number of Science Advisory & Review Boards, including for BMBF/DLR in Germany; BBSRC in the UK; Vinnova in Sweden. She has received prizes for her research, including the prestigious BMBF ‘BioFuture’ Award from the German Minister of Science. She was awarded the Federation of European Biochemical Societies (FEBS) 2009 Award for her research & its significance. Other recipients of this award include Prof. J. Craig Venter & Prof. Robert Huber.

Brief Overview:

  • Over 20 years expertise in high-throughput protein & antibody array, proteomics technology development, automation & biomedical applications in biomarker discovery, diagnostics & personalized medicine
  • Selected experience as Expert in EU over the past 15 years: EU Future & Emerging technologies (FETOPEN) Innovation Launchpad; EU Innovation Radar Expert, EU Horizon 2020 Societal Challenges 1 (Health).
  • Holds several granted and licensed international patents (EU, USA, Japan, Australia) (1995-present) and peer-reviewed publications, and reports, 
  • Professor, University College Dublin (2005-present)
  • Group Leader, Max-Planck-Institute, Berlin, Germany (1995-2003)
  • Supervisor of completed PhD & Masters’ degree students in Germany and Ireland.
  • Co-founded Protagen AG in Dortmund ( (1996-2019) as a spin-out of the Max-Planck-Institute, Berlin to commercialize her diagnostic, companion diagnostic and personalized medicine applications of her discoveries. Protagen has screened and profiled the autoantibody repertoire of over 20,000 patients (
  • Protagen Protein Services ( a spin-off company of Protagen since 2013 - expertise in protein, antibody, proteomics and peptide contract services to the pharmaceutical industry and health care sectors.

Policy and Strategy: Developing Research Infrastructure Sustainability & Integrated Healthcare Systems: 

Research, Scholarship and Innovation: Recent Keynotes and Conferences organized: 

  • Member of the Organizing Committee of the Annual World Proteome HUPO Organisation 2017 meeting held in Dublin in September 2017, chaired by UCD Prof. Stephen Pennington. Conference Gala dinner was opened by USA Vice-President Joseph R. Biden (
  • Invited to give Lectures and Keynotes at conferences including in USA, Europe, China, Japan, South Korea, Australia, South America. Recent lectures include at Companion Diagnostics & Biomarkers Conference 2019 in Porto, 13th and 14th February 2019; 5th Precision Medicine & Biomarkers Leaders’ Summit, Munich, Sept 2018 & Chair Roundtable on Personalised Medicine & Adverse Events: (

Research, Scholarship and Innovation including Policy and Strategy:

  • Expert in EU European Commission for 15 years, including Future & Emerging technologies (FETOPEN); Innovation Radar Expert; H2020 Societal Challenges 1 (Health); European Research Council.
  • Previously participated in evaluations for BMBF/DLR in Germany; UK BBSRC; Vinnova in Sweden; IWT in Belgium.
  • Examples of Science Advisory Boards Membership over past 15 years: Human Protein Atlas, Sweden; ProNova Research Institute Sweden; Complexinc, Switzerland; Atturos Ltd, Dublin.

Policy and Strategy - Seconded National Expert to the European Commission, Brussels:

  • Seconded as a National Expert in Policy to Brussels to European Commission Research & Innovation (1.10.2013- 30.9.2014) - International Cooperation for Strategy and Policy coordination.